Abstract

We monitored donor lymphoid chimerism (DLC) long term patterns by STR to investigate their clinical relevance to aGvHD. 81 out of 879 liver transplant patients (2005-2013) who clinically suspected as aGvHD were tested for DLC. Short tandem repeat (STR) assay for DLC was run on the peripheral blood, T, NK, and CD8 + T cells. Cases with positive DLC in any preparation (>5%) were monitored until resolution of DLC or patient expiration. Three characteristic patterns of subset DLC were observed. The first pattern (5 patients) is characterized by low level D% that is detected only in CD8 + T cell on initial positive test (Fig. 1). In the second pattern, four patients on the initial positive DLC, had relatively higher CD8 + T cell D% combined with positive T cell D% (Fig. 1). These two patterns were associated with effective aGvHD control with complete resolution of DLC within a mean of 21 days. In the third pattern, four patients with positive DLC in all CD8 + T cells, NK cells and T cell were associated with longer duration for DLC resolution (114 days) (Fig. 2) and failure of treatment (Fig. 2). Detection of DLC in both NK and CD8 + T cell preparations is associated with longer duration to DLC resolution and higher mortality rate. These results suggest that multi-subset DLC testing is a useful tool to support the diagnosis of aGvHD and predict the response to treatment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.